{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:29:54Z","timestamp":1780572594101,"version":"3.54.1"},"reference-count":35,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"Kala Pharmaceuticals"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pain Manag."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.2217\/pmt-2021-0023","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T10:55:56Z","timestamp":1624532156000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["KPI-121 1% for Pain and Inflammation in Ocular Surgery"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5375-8646","authenticated-orcid":false,"given":"Kenneth A","family":"Beckman","sequence":"first","affiliation":[{"name":"Comprehensive Eyecare of Central Ohio, Westerville, OH\u00a043082, USA"},{"name":"Department of Ophthalmology, Ohio State University, Columbus, OH\u00a043201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Katz","sequence":"additional","affiliation":[{"name":"The Midwest Center for Sight, Des Plaines, IL\u00a060016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag A","family":"Majmudar","sequence":"additional","affiliation":[{"name":"Chicago Cornea Consultants, Highland Park, IL\u00a060035, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron Gabriel","family":"Rips","sequence":"additional","affiliation":[{"name":"New York Medical College, Valhalla, NY 10595, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel S","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Chicago Cornea Consultants, Highland Park, IL\u00a060035, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey Talley","family":"Rostov","sequence":"additional","affiliation":[{"name":"Northwest Eye Surgeons, Seattle, WA\u00a098133, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001741"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S237405"},{"issue":"12","key":"e_1_3_2_5_1","first-page":"S215","article-title":"Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain","volume":"25","author":"Salinger C","year":"2019","unstructured":"Salinger C , GaynesBI , RajpalRK. Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain. Am. J. Managed Care.25(12), S215\u2013S226 (2019).","journal-title":"Am. J. Managed Care."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.09.027"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.10.003"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0315-8"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-012-9589-2"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R800033-JLR200"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.002"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.49"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2015.08.004"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(98)80170-3"},{"issue":"13","key":"e_1_3_2_15_1","first-page":"1065","article-title":"Comparison of loteprednol etabonate 0.5% (Lotemax) to prednisolone acetate 1% (Falcon) for inflammation treatment following cataract surgery","volume":"48","author":"Grigorian RA","year":"2007","unstructured":"Grigorian RA , ShahA , GuoA. Comparison of loteprednol etabonate 0.5% (Lotemax) to prednisolone acetate 1% (Falcon) for inflammation treatment following cataract surgery. Invest. Ophthalmol. Vis. Sci.48(13), 1065 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)99054-6"},{"key":"e_1_3_2_17_1","unstructured":"INVELTYS prescribing information. Kala Pharmaceuticals Inc (2020). https:\/\/inveltys.com\/pdf\/inveltys-prescribing-information.pdf"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S185800"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S16832"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S32643"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(01)01185-3"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2012.10.039"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-013-0059-7"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(98)80170-3"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1439920"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-014-0021-z"},{"issue":"11","key":"e_1_3_2_27_1","first-page":"3348","article-title":"The thickness of the human precorneal tear film: evidence from reflection spectra","volume":"41","author":"King-Smith PE","year":"2000","unstructured":"King-Smith PE , FinkBA , FogtN , NicholsKK , HillRM , WilsonGS. The thickness of the human precorneal tear film: evidence from reflection spectra. Invest. Ophthalmol. Vis. Sci.41(11), 3348\u20133359 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"e_1_3_2_28_1","first-page":"1996","article-title":"Study of precorneal tear film thickness and structure by interferometry and confocal microscopy","volume":"33","author":"Prydal JI","year":"1992","unstructured":"Prydal JI , CampbellFW. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest. Ophthalmol. Vis. Sci.33(6), 1996\u20132005 (1992).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"e_1_3_2_29_1","first-page":"2006","article-title":"Study of human precorneal tear film thickness and structure using laser interferometry","volume":"33","author":"Prydal JI","year":"1992","unstructured":"Prydal JI , ArtalP , WoonH , CampbellFW. Study of human precorneal tear film thickness and structure using laser interferometry. Invest. Ophthalmol. Vis. Sci.33(6), 2006\u20132011 (1992).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32830e6b04"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(01)75844-4"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.05.040"},{"key":"e_1_3_2_33_1","volume-title":"Package insert","author":"Lotemax SM","year":"2019","unstructured":"Lotemax SM , Package insert. Bausch+Lomb, NJ, USA (2019)."},{"key":"e_1_3_2_34_1","unstructured":"Bausch + Lomb . Press release. Bausch + Lomb announces FDA approval of Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38% for the treatment of postoperative inflammation and pain following ocular surgery. Designed with SM technology for efficient penetration at a low preservative (BAK) level. https:\/\/www.bausch.com\/our-company\/recent-news\/artmid\/11336\/articleid\/508\/2252019-monday"},{"key":"e_1_3_2_35_1","unstructured":"Kala Pharmaceutical . Kala Pharmaceuticals announces FDA approval of INVELTYS for the treatment of post-operative inflammation and pain following ocular surgery. Press release. (2018). http:\/\/investors.kalarx.com\/node\/7301\/pdf"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.12.010"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2020.0022"}],"container-title":["Pain Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pmt-2021-0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:47:37Z","timestamp":1715946457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pmt-2021-0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.2217\/pmt-2021-0023"],"URL":"https:\/\/doi.org\/10.2217\/pmt-2021-0023","relation":{},"ISSN":["1758-1869","1758-1877"],"issn-type":[{"value":"1758-1869","type":"print"},{"value":"1758-1877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}